# SGM-101 in Colorectal Brain Metastases.

> **NCT04755920** · PHASE2 · RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Rectal Neoplasms
- Rectum Cancer
- Colorectal Neoplasms
- Brain Metastases
- Brain Neoplasms
- Brain Diseases
- Brain Cancer
- Brain Tumor
- Intestinal Neoplasms
- Gastrointestinal Neoplasms
- Gastrointestinal Cancer
- Gastrointestinal Disease
- Intestinal Disease

## Interventions

- **DRUG:** SGM-101

## Key facts

- **NCT ID:** NCT04755920
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04755920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04755920, "SGM-101 in Colorectal Brain Metastases.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04755920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*